ArticleCardiology research and practice2022

Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients.

Joel Rodríguez-Saldaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.